Omnicell Debt to Equity Ratio 2012-2025 | OMCL
Current and historical debt to equity ratio values for Omnicell (OMCL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Omnicell debt/equity for the three months ending December 31, 2025 was 0.14.
| Omnicell Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-12-31 | $0.74B | $1.23B | 0.60 |
| 2025-09-30 | $0.73B | $1.22B | 0.60 |
| 2025-06-30 | $0.88B | $1.26B | 0.70 |
| 2025-03-31 | $0.89B | $1.26B | 0.71 |
| 2024-12-31 | $0.88B | $1.24B | 0.71 |
| 2024-09-30 | $1.07B | $1.23B | 0.87 |
| 2024-06-30 | $1.09B | $1.20B | 0.91 |
| 2024-03-31 | $1.10B | $1.19B | 0.92 |
| 2023-12-31 | $1.04B | $1.19B | 0.87 |
| 2023-09-30 | $1.03B | $1.19B | 0.87 |
| 2023-06-30 | $1.03B | $1.16B | 0.89 |
| 2023-03-31 | $1.11B | $1.14B | 0.97 |
| 2022-12-31 | $1.08B | $1.13B | 0.96 |
| 2022-09-30 | $1.04B | $1.14B | 0.92 |
| 2022-06-30 | $1.04B | $1.09B | 0.95 |
| 2022-03-31 | $1.05B | $1.08B | 0.98 |
| 2021-12-31 | $1.00B | $1.15B | 0.87 |
| 2021-09-30 | $0.94B | $1.11B | 0.85 |
| 2021-06-30 | $0.91B | $1.05B | 0.86 |
| 2021-03-31 | $0.88B | $1.01B | 0.87 |
| 2020-12-31 | $0.86B | $0.97B | 0.89 |
| 2020-09-30 | $0.80B | $0.92B | 0.87 |
| 2020-06-30 | $0.34B | $0.89B | 0.38 |
| 2020-03-31 | $0.35B | $0.88B | 0.40 |
| 2019-12-31 | $0.40B | $0.85B | 0.47 |
| 2019-09-30 | $0.44B | $0.81B | 0.54 |
| 2019-06-30 | $0.42B | $0.77B | 0.55 |
| 2019-03-31 | $0.45B | $0.73B | 0.61 |
| 2018-12-31 | $0.40B | $0.68B | 0.59 |
| 2018-09-30 | $0.43B | $0.62B | 0.70 |
| 2018-06-30 | $0.44B | $0.59B | 0.74 |
| 2018-03-31 | $0.47B | $0.58B | 0.81 |
| 2017-12-31 | $0.46B | $0.55B | 0.83 |
| 2017-09-30 | $0.45B | $0.47B | 0.96 |
| 2017-06-30 | $0.46B | $0.45B | 1.02 |
| 2017-03-31 | $0.47B | $0.44B | 1.07 |
| 2016-12-31 | $0.50B | $0.43B | 1.17 |
| 2016-09-30 | $0.50B | $0.43B | 1.18 |
| 2016-06-30 | $0.50B | $0.41B | 1.21 |
| 2016-03-31 | $0.51B | $0.41B | 1.25 |
| 2015-12-31 | $0.18B | $0.40B | 0.44 |
| 2015-09-30 | $0.19B | $0.39B | 0.47 |
| 2015-06-30 | $0.20B | $0.40B | 0.51 |
| 2015-03-31 | $0.17B | $0.41B | 0.41 |
| 2014-12-31 | $0.17B | $0.39B | 0.44 |
| 2014-09-30 | $0.17B | $0.38B | 0.44 |
| 2014-06-30 | $0.16B | $0.38B | 0.42 |
| 2014-03-31 | $0.15B | $0.37B | 0.40 |
| 2013-12-31 | $0.14B | $0.35B | 0.41 |
| 2013-09-30 | $0.15B | $0.36B | 0.41 |
| 2013-06-30 | $0.14B | $0.33B | 0.42 |
| 2013-03-31 | $0.14B | $0.32B | 0.42 |
| 2012-12-31 | $0.13B | $0.31B | 0.44 |
| 2012-09-30 | $0.13B | $0.30B | 0.42 |
| 2012-06-30 | $0.12B | $0.29B | 0.41 |
| 2012-03-31 | $0.08B | $0.29B | 0.29 |
| 2011-12-31 | $0.08B | $0.28B | 0.29 |
| 2011-09-30 | $0.08B | $0.28B | 0.29 |
| 2011-06-30 | $0.08B | $0.27B | 0.29 |
| 2011-03-31 | $0.08B | $0.27B | 0.29 |
| 2010-12-31 | $0.08B | $0.27B | 0.29 |
| 2010-09-30 | $0.08B | $0.26B | 0.30 |
| 2010-06-30 | $0.08B | $0.26B | 0.30 |
| 2010-03-31 | $0.08B | $0.25B | 0.32 |
| 2009-12-31 | $0.08B | $0.24B | 0.33 |
| 2009-09-30 | $0.08B | $0.24B | 0.32 |
| 2009-06-30 | $0.08B | $0.24B | 0.32 |
| 2009-03-31 | $0.07B | $0.24B | 0.30 |
| 2008-12-31 | $0.08B | $0.23B | 0.32 |
| 2008-09-30 | $0.08B | $0.22B | 0.34 |
| 2008-06-30 | $0.08B | $0.21B | 0.37 |
| 2008-03-31 | $0.08B | $0.23B | 0.37 |
| 2007-12-31 | $0.07B | $0.26B | 0.29 |
| 2007-09-30 | $0.07B | $0.23B | 0.28 |
| 2007-06-30 | $0.06B | $0.22B | 0.29 |
| 2007-03-31 | $0.06B | $0.10B | 0.57 |
| 2006-12-31 | $0.07B | $0.09B | 0.72 |
| 2006-09-30 | $0.06B | $0.08B | 0.74 |
| 2006-06-30 | $0.05B | $0.07B | 0.73 |
| 2006-03-31 | $0.05B | $0.06B | 0.77 |
| 2005-12-31 | $0.05B | $0.06B | 0.82 |
| 2005-09-30 | $0.05B | $0.05B | 0.97 |
| 2005-06-30 | $0.05B | $0.05B | 0.89 |
| 2005-03-31 | $0.05B | $0.05B | 0.94 |
| 2004-12-31 | $0.05B | $0.05B | 0.85 |
| 2004-09-30 | $0.05B | $0.05B | 0.94 |
| 2004-06-30 | $0.05B | $0.05B | 1.12 |
| 2004-03-31 | $0.05B | $0.04B | 1.18 |
| 2003-12-31 | $0.05B | $0.04B | 1.43 |
| 2003-09-30 | $0.04B | $0.03B | 1.47 |
| 2003-06-30 | $0.05B | $0.02B | 2.18 |
| 2003-03-31 | $0.04B | $0.02B | 2.58 |
| 2002-12-31 | $0.06B | $0.02B | 3.35 |
| 2002-09-30 | $0.05B | $0.02B | 2.22 |
| 2002-06-30 | $0.05B | $0.02B | 1.88 |
| 2002-03-31 | $0.05B | $0.02B | 2.08 |
| 2001-12-31 | $0.05B | $0.02B | 2.68 |
| 2001-09-30 | $0.05B | $0.02B | 3.05 |
| 2001-06-30 | $0.06B | $-0.02B | -3.84 |
| 2001-03-31 | $0.06B | $-0.02B | -3.89 |
| 2000-12-31 | $0.00B | 0.00 | |
| 2000-09-30 | $0.00B | 0.00 | |
| 2000-06-30 | $0.00B | 0.00 | |
| 1999-12-31 | $0.06B | $-0.02B | -2.79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.638B | $1.185B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $28.621B | 33.10 |
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Doximity (DOCS) | United States | $4.621B | 20.02 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.18 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Azenta (AZTA) | United States | $1.318B | 53.00 |
| Enovis (ENOV) | United States | $1.245B | 6.54 |
| Clover Health Investments (CLOV) | United States | $1.044B | 0.00 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.724B | 0.00 |
| Phreesia (PHR) | United States | $0.720B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |